JSGTX
Price
$22.93
Change
-$1.41 (-5.79%)
Updated
Apr 4 closing price
Net Assets
1.39B
VIGRX
Price
$171.97
Change
-$11.13 (-6.08%)
Updated
Apr 4 closing price
Net Assets
282.6B
Ad is loading...

JSGTX vs VIGRX

Header iconJSGTX vs VIGRX Comparison
Open Charts JSGTX vs VIGRXBanner chart's image
JHancock U.S. Growth R6
Price$22.93
Change-$1.41 (-5.79%)
VolumeN/A
Net Assets1.39B
Vanguard Growth Index Investor
Price$171.97
Change-$11.13 (-6.08%)
VolumeN/A
Net Assets282.6B
JSGTX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSGTX vs. VIGRX commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSGTX is a Hold and VIGRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 283B vs. JSGTX (1.39B). VIGRX pays higher dividends than JSGTX: VIGRX (0.39) vs JSGTX (0.00). JSGTX was incepted earlier than VIGRX: JSGTX (10 years) vs VIGRX (32 years). JSGTX (0.63) is less costly to investors than VIGRX (0.17). JSGTX is a more actively managed with annual turnover of: 69.00 vs. VIGRX (5.00). VIGRX has a lower initial minimum investment than JSGTX: VIGRX (3000) vs JSGTX (1000000). VIGRX annual gain was more profitable for investors over the last year : -1.09 vs. JSGTX (-11.16). VIGRX return over 5 years is better than : 122.40 vs. JSGTX (46.69).
JSGTXVIGRXJSGTX / VIGRX
Total Expense Ratio0.630.17371%
Annual Report Gross Expense Ratio0.630.17371%
Fund Existence10 years32 years-
Gain YTD-16.860-18.60991%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.39B283B0%
Annual Yield % from dividends0.000.39-
Returns for 1 year-11.16-1.091,021%
Returns for 3 years-2.2115.96-14%
Returns for 5 years46.69122.4038%
Returns for 10 years41.26210.5320%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRSN0.990.04
+4.49%
NeuroSense Therapeutics Ltd
XTKG1.11-0.01
-0.89%
X3 Holdings Co Ltd
RMD205.17-8.18
-3.83%
ResMed
AVNT30.43-2.07
-6.37%
Avient Corp
BCSF15.12-1.11
-6.84%
Bain Capital Specialty Finance